Retail sale of pharmaceutical products
NGUYEN-DOAN HOLDING AS
Revenue 2024
NOK 170,000
Operating profit
NOK −1.2m
Equity
NOK 17.5m
Incorporated
2010
Share capital
NOK 100,000
Key figures · 2024
Current ratio
4.90
Equity ratio
83.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -711.6% | |
| Net margin (%%) | -611.9% | |
| Return on assets (%%) | -5.7% | |
| Likviditet | ||
| Current ratio | 4.90 | |
| Working capital | 1.2m | |
| Soliditet | ||
| Equity ratio (%%) | 83.0% | |
| Debt-to-equity ratio | 0.20 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.